Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.39 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | NMT2 | O60551 | 1/20 | 0.36 |
| ▸ | NMT1 | P30419 | 1/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20435279 | 1.00 | FOLH1 (0.41) | FOLH1GSRSIRT6SIRT1RNPEP | |
| SCHEMBL18689009 | 1.00 | FOLH1 (0.41) | FOLH1GSRSIRT6SIRT1RNPEP | |
| SCHEMBL12392036 | 0.94 | FOLH1 (0.35) | FOLH1GSRSIRT6SIRT1RNPEP | |
| SCHEMBL22536882 | 0.86 | GABRR1 (0.41) | — | |
| SCHEMBL12812737 | 0.84 | SIRT6 (0.39) | FOLH1GSRSIRT6SIRT1RNPEP | |
| SCHEMBL13573523 | 0.83 | FOLH1 (0.40) | FOLH1GSRSIRT6SIRT1RNPEP | |
| SCHEMBL27250343 | 0.83 | FOLH1 (0.40) | FOLH1GSRSIRT6SIRT1RNPEP | |
| SCHEMBL7604714 | 0.83 | FOLH1 (0.40) | FOLH1GSRSIRT6SIRT1RNPEP | |
| SCHEMBL22062262 | 0.82 | CA1 (0.44) | — | |
| SCHEMBL14961163 | 0.81 | SIRT6 (0.43) | FOLH1GSRSIRT6SIRT1RNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209382-A1 | NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME | UNIVERSITY OF DELAWARE | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209382-A1 | NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME | RNGTT, HBS1L, BROX | FOLH1 1684/4885GSR 2461/4885SIRT6 3742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.